IBSA Institut Biochimique SA   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Lugano Switzerland (1945)
Status: No NME R&D (1945)

Organization Overview

First Clinical Trial
2001
NCT00464607
First Marketed Drug
2006
levothyroxine (Synthroid)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

IBSA INST BIO | IBSA Institut Biochimique SA | INST BIOCHEM | INSTITUT BIOCHIMIQUE